Bionano Genomics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Bionano Genomics, Inc. (BNGO) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-112.02-232.49-132.60-72.44-41.11-29.82-18.50
Depreciation & Amortization14.2313.379.843.371.481.131.32
Deferred Income Tax0.000.001.76-5.780.000.000.00
Stock Based Compensation9.7415.1822.429.721.550.000.00
Change in Working Capital4.40-14.77-27.94-7.65-3.44-4.97-2.37
Change in Accounts Receivable4.14-2.30-2.25-0.492.090.000.00
Change in Inventory-0.59-4.15-23.68-15.93-4.200.000.00
Change in Accounts Payable-3.42-2.001.956.78-1.810.000.00
Change in Other Working Capital4.27-6.330.791.990.480.000.00
Other Operating Activities14.73110.150.79-4.934.752.780.87
Net Cash from Operating Activities-68.92-125.18-124.82-71.93-38.31-29.50-19.94
Investing Activities
Capital Expenditures-0.101.69-3.30-1.460.000.06-0.33
Acquisitions0.00-1.46-31.34-49.09-2.450.000.00
Purchases of Investments-233.0225.75-84.20-226.910.000.000.00
Sales/Maturities of Investments306.9625.85200.89-228.340.000.000.00
Other Investing Activities0.000.100.69-0.610.000.000.00
Net Cash from Investing Activities73.8424.1682.77-278.06-2.45-0.06-0.33
Financing Activities
Debt Repayment-48.06-13.57-0.04-15.01-7.26-14.43-7.45
Common Stock Issued44.4357.7023.13352.8239.9319.5619.39
Common Stock Repurchased0.000.000.000.00-2.000.000.00
Other Financing Activities-10.06-8.89-0.58-1.701.810.140.00
Net Cash from Financing Activities-13.69113.8223.01336.1161.9030.3835.78
Summary
Effect of Forex Changes on Cash-0.010.07-0.040.000.000.000.00
Net Change in Cash-8.7812.79-19.04-13.8823.590.7915.50
Cash at Beginning of Period18.355.4924.5738.4517.3116.521.02
Cash at End of Period9.5718.355.4973.6640.9017.3116.52
Free Cash Flow-69.03-126.87-128.12-73.39-38.31-29.56-20.28
Supplemental Disclosures
Interest Paid10.651.650.301.911.251.280.70